Back to search
Human Papillomavirus-Related Cervical Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Human Papillomavirus-Related Cervical Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Human Papillomavirus-Related Cervical Carcinoma trials you may qualify forThis Phase 2 study will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab in patients with pembrolizumab-resistant recurrent or me…
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. Oropharynx SCC (OPSCC) is a common sub-type of HNSCC. Each year, 16,000 new cases…
This study will look at whether monitoring HPV ctDNA levels is an effective way to detect cancer relapse risk in people with HPV-OPC. All participants will have…
This is a research study for individuals who have cancer associated with human papillomavirus (HPV) and are being treated with radiation as part of standard car…
This is a phase II clinical trial to assess the clinical activity of immunotherapy with E7 TCR-T cells for metastatic HPV-associated cancers. HPV-associated can…
The goal of this study is to determine the feasibility of administration of a single dose of E7 TCR-T cells as induction therapy prior to definitive treatment (…
This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the ope…
This trial studies how well magnetic resonance imaging (MRI)-guided internal radiation therapy (brachytherapy) works in treating participants with human papillo…